nitroglycerin has been researched along with Pulmonary Hypertension in 108 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the effects of dobutamine and nitroglycerin to milrinone in young patients with severe pulmonary hypertension undergoing mitral valve replacement." | 9.27 | Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study. ( Abu Elkassem, MS; Elmiligy, AE; Eskandr, AM; Hussein, L; Metwally, AA; Mourad, M; Sadik, SA, 2018) |
| " Keywords used were "Pulmonary Hypertension", "Congenital heart defects", "Pediatrics", "Inhaled nitroglycerin", and its synonyms." | 9.12 | Nitroglycerin inhalation for acute treatment of pulmonary arterial hypertension in children with congenital heart disease. ( Marwali, EM; Rayhan, M; Roebiono, PS, 2021) |
| "This study explores the effect and mechanisms of inhalation of nebulized nitroglycerin (Neb-NTG) on pulmonary hypertension induced by high pulmonary blood flow." | 7.73 | Inhalation of nebulized nitroglycerin, a nitric oxide donor, for the treatment of pulmonary hypertension induced by high pulmonary blood flow. ( Chaoshu, T; Chunyu, Z; Jin, F; Junbao, D; Puikuan, K, 2006) |
| "The aim of this study was to investigate the postoperative hemodynamic effects of nitroglycerin inhalation on patients with pulmonary hypertension undergoing mitral valve replacement surgery." | 7.72 | Effect of nitroglycerin inhalation on patients with pulmonary hypertension undergoing mitral valve replacement surgery. ( Aksoy, T; Canik, S; Kaplan, M; Karaca, P; Kopman, E; Ozkul, V; Tuygun, AK; Yurtseven, N, 2003) |
| "Acute hemodynamic effects of beraprost sodium were tested in a canine vasoconstrictive pulmonary hypertension model induced by the continuous infusion of U-46619, a thromboxane A(2)mimetic." | 7.71 | Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension. ( Kurumatani, H; Matsushita, T; Tamura, M, 2001) |
| "In 29 patients with advanced heart failure, therapy tailored to hemodynamic goals was attempted using an initial infusion of dobutamine and nitroglycerin (the latter in those with pulmonary hypertension) followed by escalating doses of oral vasodilators." | 7.70 | Tailored therapy using dobutamine and nitroglycerin in advanced heart failure. ( Drazner, MH; Solomon, MA; Thompson, B; Yancy, CW, 1999) |
| " vasodilator agent, nitroglycerin, or ciloprost, a prostacyclin analogue, during acute pulmonary hypertension in pigs, induced by continuous infusion of a thromboxane analogue (U46619), adjusted to maintain mean pulmonary artery pressure (MPAP) at 40 mm Hg." | 7.69 | Combination of inhaled nitric oxide with i.v. nitroglycerin or with a prostacyclin analogue in the treatment of experimental pulmonary hypertension. ( Blaise, G; Charbonneau, M; Van Obbergh, LJ, 1996) |
| "The effects of ligustrazine and nitroglycerine on acute hypoxic pulmonary hypertension were observed in 10 anesthetized dogs." | 7.69 | [Effects of ligustrazine and nitroglycerine on acute hypoxic pulmonary hypertension in anesthetized dogs]. ( Cao, W; Guo, Z; Luo, W, 1994) |
| " In the current study, we compared the effects of inhaled nitric oxide and intravenous nitroglycerine on pulmonary and systemic haemodynamic responses as well as on gas exchange measurements in anaesthetized pigs whose pulmonary pressure was increased by hypoxia (FiO2 = 15%)." | 7.69 | Comparison of the effect of inhaled nitric oxide and intravenous nitroglycerine on hypoxia-induced pulmonary hypertension in pigs. ( Blaise, G; Charbonneau, M; Collet, JP; da Silva, P; Ducruet, T; Jacob, E; Salazkin, I; Troncy, E, 1996) |
| "The postoperative effect of infusion of nitroglycerin on pulmonary vasomotor dynamics was studied in 28 patients undergoing valve replacement for mitral valve stenosis." | 7.67 | The effect of low-dose intravenous nitroglycerin on pulmonary hypertension immediately after replacement of a stenotic mitral valve. ( Goor, DA; Mohr, R; Pohoryles, L; Quang, HT; Ruvolo, G; Smolinsky, A; Ziskind, Z, 1985) |
| "Kinetocardiography and integral rheography of the body were used to examine the effect of nitroglycerin on the hemodynamics in 17 patients with chronic obstructive bronchitis complicated by pulmonary hypertension." | 7.67 | [Effect of nitroglycerin on various indicators of hemodynamics in patients with chronic obstructive bronchitis complicated by pulmonary hypertension]. ( Aleksandrov, AL; Cherniakova, TG; Matkovskii, SK, 1985) |
| "Administration of intravenous nitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance." | 7.67 | Paradoxical pulmonary vasoconstriction induced by nitroglycerin in idiopathic pulmonary hypertension. ( Gregoratos, G; Hoit, B; Shabetai, R, 1985) |
| "In 41 patients with chronic obstructive pulmonary disease (COPD) and pulmonary hypertension, the effects of sublingual administration of 20 mg nifedipine and 0." | 7.67 | [Vasodilator therapy in pulmonary hypertension and chronic obstructive lung disease (COPD). Hemodynamic studies exemplified by nifedipine and nitroglycerin]. ( Fridrich, L; Gassner, A; Klicpera, M; Magometschnigg, D; Sommer, G, 1986) |
| "The hemodynamic effects of nitroglycerin (TNG) and sodium nitroprusside (SNP) were studied in a canine model of pulmonary hypertension." | 7.66 | Pulmonary vasodilator effects of nitroglycerin and sodium nitroprusside in canine oleic acid-induced pulmonary hypertension. ( Ashton, JP; Pearl, RG; Rosenthal, MH, 1983) |
| "We have studied the hemodynamic effects of an intravenous single dose of nitroglycerin in 13 patients with secondary pulmonary hypertension and Cor Pulmonale, during the acute course of respiratory failure and under assisted ventilation." | 7.66 | Intravenous nitroglycerin in acute respiratory failure of patients with chronic obstructive lung disease, secondary pulmonary hypertension and cor pulmonale. ( Chopin, C; Dubois, D; Durocher, A; Fourrier, F; Wattel, F, 1982) |
| "The results of functional pharmacological tests with nitroglycerine and carbon dioxide gas are presented for patients with congenital heart diseases and pulmonary hypertension, as shown during right heart catheterization." | 7.65 | [Study of the pulmonary vessel reaction to administration of carbon dioxide and nitroglycerin in congenital heart defects complicated by high pulmonary hypertension]. ( Antonov, OS; Litasova, EE; Obukhov, VN; Pinegin, SL; Vlasov, IuA, 1977) |
| " The administration of iloprost after bypass (T3) at a dosage of 1." | 5.33 | Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery. ( Baysal, A; Bilsel, S; Bulbul, OG; Idiz, M; Kayacioglu, I; Yekeler, I, 2006) |
| "Pulmonary artery pressure (PAP), right ventricular hypertrophy (RVH), NO-related relaxation and tissue ET-1 levels in PA were evaluated and compared with control (C)." | 5.29 | Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats. ( Gewitz, MH; Mathew, R; Tun, H; Zeballos, GA, 1995) |
| "To compare the effects of dobutamine and nitroglycerin to milrinone in young patients with severe pulmonary hypertension undergoing mitral valve replacement." | 5.27 | Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study. ( Abu Elkassem, MS; Elmiligy, AE; Eskandr, AM; Hussein, L; Metwally, AA; Mourad, M; Sadik, SA, 2018) |
| "Therapy of pulmonary hypertension is limited by the low potency and adverse effects of current pulmonary vasodilators." | 5.27 | Acute hemodynamic effects of nitroglycerin in pulmonary hypertension. ( Ashton, JP; Pearl, RG; Rosenthal, MH; Schroeder, JS, 1983) |
| "We conclude that pulmonary hypertension is probably a result of chronic hypoxemia experienced by patients with pulmonary hemosiderosis." | 5.27 | Nitroglycerin-responsive pulmonary hypertension in idiopathic pulmonary hemosiderosis. ( Frankel, LR; Lewiston, NJ; Pearl, RG; Smith, DW, 1986) |
| "Pulmonary hypertension was induced by an iv infusion of group B Streptococci." | 5.27 | Neither nitroglycerin nor nitroprusside selectively reduces sepsis-induced pulmonary hypertension in piglets. ( Komar, KJ; Meadow, WL; Rudinsky, BF; Strates, E, 1987) |
| " Keywords used were "Pulmonary Hypertension", "Congenital heart defects", "Pediatrics", "Inhaled nitroglycerin", and its synonyms." | 5.12 | Nitroglycerin inhalation for acute treatment of pulmonary arterial hypertension in children with congenital heart disease. ( Marwali, EM; Rayhan, M; Roebiono, PS, 2021) |
| "Enoximone or DOB and NTG have comparable effects on CO, PSA, and HR in mitral regurgitation and pulmonary hypertension, but EN is more effective in reducing PPA without deterioration of gas exchange." | 5.08 | Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension. ( Brüssel, T; Hachenberg, T; Hammel, D; Holst, D; Möllhoff, T, 1997) |
| "We reviewed the charts of eight adult patients with postoperative pulmonary hypertension who received oral sildenafil (25 to 50 mg) to facilitate weaning of IV (milrinone, nitroglycerine, and sodium nitroprusside) and inhaled (nitric oxide) pulmonary vasodilators." | 4.82 | Oral sildenafil reduces pulmonary hypertension after cardiac surgery. ( Beaver, TM; Hess, PJ; Klodell, CT; Lobato, EB; Martin, TD; Staples, ED; Trachte, AL; Urdaneta, F, 2005) |
| "This study explores the effect and mechanisms of inhalation of nebulized nitroglycerin (Neb-NTG) on pulmonary hypertension induced by high pulmonary blood flow." | 3.73 | Inhalation of nebulized nitroglycerin, a nitric oxide donor, for the treatment of pulmonary hypertension induced by high pulmonary blood flow. ( Chaoshu, T; Chunyu, Z; Jin, F; Junbao, D; Puikuan, K, 2006) |
| "The aim of this study was to investigate the postoperative hemodynamic effects of nitroglycerin inhalation on patients with pulmonary hypertension undergoing mitral valve replacement surgery." | 3.72 | Effect of nitroglycerin inhalation on patients with pulmonary hypertension undergoing mitral valve replacement surgery. ( Aksoy, T; Canik, S; Kaplan, M; Karaca, P; Kopman, E; Ozkul, V; Tuygun, AK; Yurtseven, N, 2003) |
| " Sodium nitroprusside is given to half of the subjects and nitroglycerine is given to the other half in order to lower pulmonary hypertension." | 3.72 | [The effects of hypertonic NaCl (7.5%) in dogs with induced acute pulmonary artery obstruction]. ( Balci, A; Cakir, O; Eren, NM; Eren, S; Satici, O; Ulkü, R, 2003) |
| "The study consisted of six groups (N=30; five rabbits/group): (1) Control with no pretreatment, monocrotaline injected groups: (solutions were perfused following termination of CPB for 60 min); (2) Control for pulmonary hypertension (PHT); (3) isoproteronol; (4) VIP 10(-6) M; (5) VIP 10(-5) M; (6) nitroglycerine." | 3.71 | The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine. ( Chang, D; Gunaydin, S; Hagino, I; Imai, Y; Seo, K; Shinoka, T; Takanashi, Y, 2002) |
| "Acute hemodynamic effects of beraprost sodium were tested in a canine vasoconstrictive pulmonary hypertension model induced by the continuous infusion of U-46619, a thromboxane A(2)mimetic." | 3.71 | Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension. ( Kurumatani, H; Matsushita, T; Tamura, M, 2001) |
| "In 29 patients with advanced heart failure, therapy tailored to hemodynamic goals was attempted using an initial infusion of dobutamine and nitroglycerin (the latter in those with pulmonary hypertension) followed by escalating doses of oral vasodilators." | 3.70 | Tailored therapy using dobutamine and nitroglycerin in advanced heart failure. ( Drazner, MH; Solomon, MA; Thompson, B; Yancy, CW, 1999) |
| " In the current study, we compared the effects of inhaled nitric oxide and intravenous nitroglycerine on pulmonary and systemic haemodynamic responses as well as on gas exchange measurements in anaesthetized pigs whose pulmonary pressure was increased by hypoxia (FiO2 = 15%)." | 3.69 | Comparison of the effect of inhaled nitric oxide and intravenous nitroglycerine on hypoxia-induced pulmonary hypertension in pigs. ( Blaise, G; Charbonneau, M; Collet, JP; da Silva, P; Ducruet, T; Jacob, E; Salazkin, I; Troncy, E, 1996) |
| " vasodilator agent, nitroglycerin, or ciloprost, a prostacyclin analogue, during acute pulmonary hypertension in pigs, induced by continuous infusion of a thromboxane analogue (U46619), adjusted to maintain mean pulmonary artery pressure (MPAP) at 40 mm Hg." | 3.69 | Combination of inhaled nitric oxide with i.v. nitroglycerin or with a prostacyclin analogue in the treatment of experimental pulmonary hypertension. ( Blaise, G; Charbonneau, M; Van Obbergh, LJ, 1996) |
| "Twelve beagles (pulmonary hypertension, n = 6; control group, n = 6) were studied during baseline conditions and during right atrial infusion of FR139317 (an ETA receptor antagonist), RES-701-1 (an ETB receptor antagonist), nitroglycerin and prostaglandin E1." | 3.69 | Endothelin receptor antagonists in a beagle model of pulmonary hypertension: contribution to possible potential therapy? ( Okada, K; Okada, M; Yamashita, C, 1995) |
| "The effects of ligustrazine and nitroglycerine on acute hypoxic pulmonary hypertension were observed in 10 anesthetized dogs." | 3.69 | [Effects of ligustrazine and nitroglycerine on acute hypoxic pulmonary hypertension in anesthetized dogs]. ( Cao, W; Guo, Z; Luo, W, 1994) |
| "In eight anesthetized ventilated goats, the hemodynamic effect of isoproterenol (ISU), dopamine (DOP), norepinephrine (NE), nitroglycerin (NTG), and Ringer's lactate (RL) infusion was evaluated after inducing acute pulmonary hypertension (PHN) to decrease cardiac output." | 3.67 | Treatment of low cardiac output complicating acute pulmonary hypertension in normovolemic goats. ( Mathru, M; Shirakawa, Y; Smith, RA; Sugiura, A; Venus, B, 1986) |
| "In 41 patients with chronic obstructive pulmonary disease (COPD) and pulmonary hypertension, the effects of sublingual administration of 20 mg nifedipine and 0." | 3.67 | [Vasodilator therapy in pulmonary hypertension and chronic obstructive lung disease (COPD). Hemodynamic studies exemplified by nifedipine and nitroglycerin]. ( Fridrich, L; Gassner, A; Klicpera, M; Magometschnigg, D; Sommer, G, 1986) |
| "Administration of intravenous nitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance." | 3.67 | Paradoxical pulmonary vasoconstriction induced by nitroglycerin in idiopathic pulmonary hypertension. ( Gregoratos, G; Hoit, B; Shabetai, R, 1985) |
| "Kinetocardiography and integral rheography of the body were used to examine the effect of nitroglycerin on the hemodynamics in 17 patients with chronic obstructive bronchitis complicated by pulmonary hypertension." | 3.67 | [Effect of nitroglycerin on various indicators of hemodynamics in patients with chronic obstructive bronchitis complicated by pulmonary hypertension]. ( Aleksandrov, AL; Cherniakova, TG; Matkovskii, SK, 1985) |
| "The postoperative effect of infusion of nitroglycerin on pulmonary vasomotor dynamics was studied in 28 patients undergoing valve replacement for mitral valve stenosis." | 3.67 | The effect of low-dose intravenous nitroglycerin on pulmonary hypertension immediately after replacement of a stenotic mitral valve. ( Goor, DA; Mohr, R; Pohoryles, L; Quang, HT; Ruvolo, G; Smolinsky, A; Ziskind, Z, 1985) |
| "We have studied the hemodynamic effects of an intravenous single dose of nitroglycerin in 13 patients with secondary pulmonary hypertension and Cor Pulmonale, during the acute course of respiratory failure and under assisted ventilation." | 3.66 | Intravenous nitroglycerin in acute respiratory failure of patients with chronic obstructive lung disease, secondary pulmonary hypertension and cor pulmonale. ( Chopin, C; Dubois, D; Durocher, A; Fourrier, F; Wattel, F, 1982) |
| "Vasodilators including isoproterenol, nitroprusside, nitroglycerin, and oxygen were administered to 5 patients with chronic pulmonary hypertension secondary to pulmonary embolism." | 3.66 | Partial reversibility of chronic pulmonary hypertension caused by pulmonary thromboembolic disease. ( Bower, JS; Dantzker, DR, 1981) |
| "The hemodynamic effects of nitroglycerin (TNG) and sodium nitroprusside (SNP) were studied in a canine model of pulmonary hypertension." | 3.66 | Pulmonary vasodilator effects of nitroglycerin and sodium nitroprusside in canine oleic acid-induced pulmonary hypertension. ( Ashton, JP; Pearl, RG; Rosenthal, MH, 1983) |
| "The results of functional pharmacological tests with nitroglycerine and carbon dioxide gas are presented for patients with congenital heart diseases and pulmonary hypertension, as shown during right heart catheterization." | 3.65 | [Study of the pulmonary vessel reaction to administration of carbon dioxide and nitroglycerin in congenital heart defects complicated by high pulmonary hypertension]. ( Antonov, OS; Litasova, EE; Obukhov, VN; Pinegin, SL; Vlasov, IuA, 1977) |
| "Iloprost was administered during weaning from cardiopulmonary bypass (CPB)." | 2.73 | Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. ( Autschbach, R; Buhre, W; de Waal, EE; Flier, S; Metzelder, S; Rex, S; Rossaint, R; Schaelte, G, 2008) |
| "44 patients (pts) with dilated cardiomyopathy (Group I) and 34 patients with ischemic heart disease (Group II) were assessed." | 2.72 | Markers of pulmonary hypertension in potential candidates to heart transplantation. ( Drwiła, R; Kapelak, B; Konstanty, J; Krochin, M; Marek, G; Piatek, J; Podolec, P; Przybyłowski, P; Rudziński, P; Sadowski, J; Sobczyk, D; Wierzbicki, K; Wójcik, S; Wróbel, K, 2006) |
| "vasodilators for treatment of pulmonary hypertension (PH) after cardiac surgery, but iNO is a potentially toxic gas, and patient subsets who benefit from iNO are not yet clearly defined." | 2.69 | Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery. ( Bürki, C; Engel, MH; Schmid, ER; Schmidlin, D; Seifert, B; Tornic, M, 1999) |
| "Nitroglycerin has theoretic appeal as a vasodilator drug in patients with pulmonary hypertension because it exerts a direct effect on the pulmonary circulation in doses that do not affect systemic resistance vessels or the myocardium and do not activate neurohumoral reflexes." | 2.37 | Nitroglycerin therapy in the management of pulmonary hypertensive disorders. ( Brooks, KM; Halperin, JL; Lee, WH; Packer, M; Rothlauf, EB, 1984) |
| "Chronic left-heart failure is often associated with the development of pulmonary venous hypertension." | 1.34 | Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. ( Braun, S; Schmeisser, A; Schrötter, H; Strasser, RH, 2007) |
| " The administration of iloprost after bypass (T3) at a dosage of 1." | 1.33 | Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery. ( Baysal, A; Bilsel, S; Bulbul, OG; Idiz, M; Kayacioglu, I; Yekeler, I, 2006) |
| "Nitroglycerine infusion was started at 10 mg x hr(-1) shortly after the initiation of DPD." | 1.31 | Treatment of pulmonary hypertension during surgery with nitric oxide and vasodilators. ( Blaise, G; Costachescu, T; Derouin, M; Jiang, ZY, 2000) |
| "Nitroglycerin was administrated either by inhalation or by infusion." | 1.30 | Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction. ( Bando, M; Ishii, Y; Kitamura, S; Ohno, S, 1998) |
| "Pregnancy was managed to term before she progressed to NYHA Class IV and cardiac failure at 37 wk gestation." | 1.30 | Cesarean section in a mother with uncorrected congenital coronary to pulmonary artery fistula. ( Ong, BC; Tan, SA; Tay, SM, 1999) |
| " In contrast, pretreatment with L-NAME resulted in no changes in the dose-response characteristics of the cyclic adenosine monophosphate-mediated, NO-independent vasodilators prostaglandin E1 and 5'-N-ethylcarboxamidoadenosine." | 1.29 | Inhibition of endogenous nitric oxide synthase potentiates nitrovasodilators in experimental pulmonary hypertension. ( Kavanagh, BP; Pearl, RG; Thompson, JS, 1996) |
| "Pulmonary artery pressure (PAP), right ventricular hypertrophy (RVH), NO-related relaxation and tissue ET-1 levels in PA were evaluated and compared with control (C)." | 1.29 | Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats. ( Gewitz, MH; Mathew, R; Tun, H; Zeballos, GA, 1995) |
| "Hydralazine was the only drug that significantly increased cardiac output (1." | 1.28 | Vasodilator therapy in microembolic porcine pulmonary hypertension. ( McLean, RF; Pearl, RG; Prielipp, RC; Rosenthal, MH, 1990) |
| "We conclude that pulmonary hypertension is probably a result of chronic hypoxemia experienced by patients with pulmonary hemosiderosis." | 1.27 | Nitroglycerin-responsive pulmonary hypertension in idiopathic pulmonary hemosiderosis. ( Frankel, LR; Lewiston, NJ; Pearl, RG; Smith, DW, 1986) |
| "Pulmonary hypertension was induced by an iv infusion of group B Streptococci." | 1.27 | Neither nitroglycerin nor nitroprusside selectively reduces sepsis-induced pulmonary hypertension in piglets. ( Komar, KJ; Meadow, WL; Rudinsky, BF; Strates, E, 1987) |
| "Therapy of pulmonary hypertension is limited by the low potency and adverse effects of current pulmonary vasodilators." | 1.27 | Acute hemodynamic effects of nitroglycerin in pulmonary hypertension. ( Ashton, JP; Pearl, RG; Rosenthal, MH; Schroeder, JS, 1983) |
| "Nitroglycerin was used to treat systemic or pulmonary hypertension, myocardial ischaemia and ventricular failure." | 1.27 | A profile of intravenous nitroglycerin use in cardiopulmonary bypass surgery. ( Bessette, MC; Cohen, AY; Townsend, GE; Whalley, DG; Wynands, JE, 1983) |
| "Nitroglycerin therapy can cause dose-related increases in intracranial pressure." | 1.27 | Intravenous nitroglycerin-induced intracranial hypertension. ( Fowler, AA; Glauser, FL; Ohar, JM; Selhorst, JB, 1985) |
| "If bronchospasmolytic agents are added, hypoxemia can be prohibited." | 1.26 | [The distribution of ventilation and perfusion in the obstructive syndrome during nitroglycerin and bronchospasmolytic therapy]. ( Borkenstein, J, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 52 (48.15) | 18.7374 |
| 1990's | 21 (19.44) | 18.2507 |
| 2000's | 25 (23.15) | 29.6817 |
| 2010's | 8 (7.41) | 24.3611 |
| 2020's | 2 (1.85) | 2.80 |
| Authors | Studies |
|---|---|
| Nilsson, KF | 2 |
| Gozdzik, W | 2 |
| Zielinski, S | 2 |
| Ratajczak, K | 2 |
| Göranson, SP | 1 |
| Rodziewicz, S | 2 |
| Harbut, P | 1 |
| Barteczko-Grajek, B | 1 |
| Albert, J | 2 |
| Frostell, C | 2 |
| Marwali, EM | 1 |
| Rayhan, M | 1 |
| Roebiono, PS | 1 |
| Ghio, S | 2 |
| Crimi, G | 1 |
| Temporelli, PL | 1 |
| Traversi, E | 1 |
| La Rovere, MT | 1 |
| Cannito, A | 1 |
| Vizza, D | 1 |
| Scelsi, L | 2 |
| Raineri, C | 2 |
| Guazzi, M | 1 |
| Oltrona Visconti, L | 1 |
| Zielińska, M | 1 |
| Skrzypczak, P | 1 |
| Gustafsson, LE | 1 |
| Minatsuki, S | 1 |
| Kiyosue, A | 1 |
| Saito, A | 1 |
| Maki, H | 1 |
| Hatano, M | 1 |
| Komuro, I | 1 |
| Eskandr, AM | 1 |
| Metwally, AA | 1 |
| Abu Elkassem, MS | 1 |
| Sadik, SA | 1 |
| Elmiligy, AE | 1 |
| Mourad, M | 1 |
| Hussein, L | 1 |
| Gu, Z | 1 |
| Xin, L | 1 |
| Wang, Z | 1 |
| Wang, J | 1 |
| Mosing, M | 1 |
| Kutter, AP | 1 |
| Iff, S | 1 |
| Raszplewicz, J | 1 |
| Mauch, J | 1 |
| Bohm, SH | 1 |
| Tusman, G | 1 |
| Gurney, AM | 1 |
| Howarth, FC | 1 |
| Stehlik, J | 1 |
| Movsesian, MA | 1 |
| Koczmara, C | 1 |
| Hyland, S | 1 |
| Greenall, J | 1 |
| Singh, R | 1 |
| Choudhury, M | 1 |
| Saxena, A | 1 |
| Kapoor, PM | 1 |
| Juneja, R | 2 |
| Kiran, U | 3 |
| Kim, JS | 1 |
| Nam, MH | 1 |
| Do, YS | 1 |
| Lee, CJ | 1 |
| Kim, CS | 1 |
| Sim, WS | 1 |
| Park, KB | 1 |
| Lee, SH | 1 |
| Han, JS | 1 |
| Shin, BS | 1 |
| Kim, HY | 1 |
| Lowson, SM | 1 |
| Gavazzi, A | 1 |
| Campana, C | 1 |
| Klersy, C | 1 |
| Serio, A | 1 |
| Tavazzi, L | 1 |
| PERLICK, E | 1 |
| Yurtseven, N | 2 |
| Karaca, P | 2 |
| Kaplan, M | 1 |
| Ozkul, V | 2 |
| Tuygun, AK | 2 |
| Aksoy, T | 1 |
| Canik, S | 2 |
| Kopman, E | 1 |
| Ulkü, R | 1 |
| Eren, NM | 1 |
| Cakir, O | 1 |
| Satici, O | 1 |
| Balci, A | 1 |
| Eren, S | 1 |
| Fan, J | 1 |
| Du, JB | 1 |
| Trachte, AL | 1 |
| Lobato, EB | 1 |
| Urdaneta, F | 1 |
| Hess, PJ | 1 |
| Klodell, CT | 1 |
| Martin, TD | 1 |
| Staples, ED | 1 |
| Beaver, TM | 1 |
| Makhija, N | 1 |
| Das, SN | 1 |
| Bhan, A | 1 |
| Airan, B | 1 |
| Ocal, A | 1 |
| Kiriş, I | 1 |
| Erdinç, M | 1 |
| Peker, O | 1 |
| Yavuz, T | 1 |
| Ibrişim, E | 1 |
| Hughes, R | 1 |
| Tong, J | 1 |
| Oates, C | 1 |
| Lordan, J | 1 |
| Corris, PA | 1 |
| Baysal, A | 1 |
| Bilsel, S | 1 |
| Bulbul, OG | 1 |
| Kayacioglu, I | 1 |
| Idiz, M | 1 |
| Yekeler, I | 1 |
| Goyal, P | 1 |
| Chauhan, S | 1 |
| Choudhary, M | 1 |
| Puikuan, K | 1 |
| Chunyu, Z | 1 |
| Jin, F | 1 |
| Chaoshu, T | 1 |
| Junbao, D | 1 |
| Braun, S | 1 |
| Schrötter, H | 1 |
| Schmeisser, A | 1 |
| Strasser, RH | 1 |
| Uysal, G | 1 |
| Cimen, S | 1 |
| Yuksek, A | 1 |
| Wolff, B | 1 |
| Lodziewski, S | 1 |
| Bollmann, T | 1 |
| Opitz, CF | 1 |
| Ewert, R | 1 |
| Wierzbicki, K | 1 |
| Przybyłowski, P | 1 |
| Sobczyk, D | 1 |
| Konstanty, J | 1 |
| Kapelak, B | 1 |
| Drwiła, R | 1 |
| Krochin, M | 1 |
| Podolec, P | 1 |
| Wójcik, S | 1 |
| Marek, G | 1 |
| Wróbel, K | 1 |
| Piatek, J | 1 |
| Rudziński, P | 1 |
| Sadowski, J | 1 |
| Rex, S | 1 |
| Schaelte, G | 1 |
| Metzelder, S | 1 |
| Flier, S | 1 |
| de Waal, EE | 1 |
| Autschbach, R | 1 |
| Rossaint, R | 1 |
| Buhre, W | 1 |
| Townsend, GE | 1 |
| Wynands, JE | 1 |
| Whalley, DG | 1 |
| Cohen, AY | 1 |
| Bessette, MC | 1 |
| Brent, BN | 1 |
| Berger, HJ | 1 |
| Matthay, RA | 1 |
| Mahler, D | 1 |
| Pytlik, L | 1 |
| Zaret, BL | 1 |
| Pearl, RG | 7 |
| Rosenthal, MH | 5 |
| Ashton, JP | 2 |
| Schroeder, JS | 1 |
| Coma-Canella, I | 1 |
| Lopez-Sendon, J | 1 |
| Drummond, WH | 2 |
| Lock, JE | 1 |
| Pribylova, NN | 1 |
| Goloshchapov, OA | 1 |
| Parygina, EI | 1 |
| Konstam, MA | 1 |
| Salem, DN | 1 |
| Isner, JM | 1 |
| Zile, MR | 1 |
| Kahn, PC | 1 |
| Bonin, JD | 1 |
| Cohen, SR | 1 |
| Levine, HJ | 1 |
| Packer, M | 1 |
| Halperin, JL | 2 |
| Brooks, KM | 2 |
| Rothlauf, EB | 2 |
| Lee, WH | 1 |
| Dantzker, DR | 1 |
| Bower, JS | 1 |
| Fourrier, F | 1 |
| Chopin, C | 1 |
| Durocher, A | 1 |
| Dubois, D | 1 |
| Wattel, F | 1 |
| Iwanami, H | 1 |
| Yamaguchi, S | 1 |
| Nakajima, M | 1 |
| Aida, H | 1 |
| Sakamoto, S | 1 |
| Anzai, Y | 1 |
| Watanabe, K | 1 |
| Okada, M | 2 |
| Yamashita, C | 1 |
| Okada, K | 1 |
| Volkova, LI | 2 |
| Shteĭngart, IuN | 1 |
| Romand, JA | 1 |
| Pinsky, MR | 1 |
| Firestone, L | 1 |
| Zar, HA | 1 |
| Lancaster, JR | 1 |
| Cao, W | 1 |
| Luo, W | 1 |
| Guo, Z | 1 |
| Koizumi, T | 1 |
| Kubo, K | 1 |
| Hirai, K | 1 |
| Shinozaki, S | 1 |
| Kobayashi, T | 1 |
| Sekiguchi, M | 1 |
| Sakai, A | 1 |
| Mathew, R | 1 |
| Zeballos, GA | 1 |
| Tun, H | 1 |
| Gewitz, MH | 1 |
| Taura, P | 1 |
| Garcia-Valdecasas, JC | 1 |
| Beltran, J | 1 |
| Izquierdo, E | 1 |
| Navasa, M | 1 |
| Sala-Blanch, J | 1 |
| Mas, A | 1 |
| Balust, J | 1 |
| Grande, L | 1 |
| Visa, J | 1 |
| Kavanagh, BP | 1 |
| Thompson, JS | 1 |
| Van Obbergh, LJ | 1 |
| Charbonneau, M | 2 |
| Blaise, G | 3 |
| Troncy, E | 1 |
| Jacob, E | 1 |
| da Silva, P | 1 |
| Ducruet, T | 1 |
| Collet, JP | 1 |
| Salazkin, I | 1 |
| Hachenberg, T | 1 |
| Möllhoff, T | 1 |
| Holst, D | 1 |
| Hammel, D | 1 |
| Brüssel, T | 1 |
| Bundgaard, H | 1 |
| Boesgaard, S | 1 |
| Mortensen, SA | 1 |
| Arendrup, H | 1 |
| Aldershvile, J | 1 |
| Bando, M | 1 |
| Ishii, Y | 1 |
| Kitamura, S | 1 |
| Ohno, S | 1 |
| Hyman, AL | 1 |
| Hao, Q | 1 |
| Tower, A | 1 |
| Kadowitz, PJ | 1 |
| Champion, HC | 1 |
| Gumusel, B | 1 |
| Lippton, H | 1 |
| Tay, SM | 1 |
| Ong, BC | 1 |
| Tan, SA | 1 |
| Drazner, MH | 1 |
| Solomon, MA | 1 |
| Thompson, B | 1 |
| Yancy, CW | 1 |
| Schmid, ER | 1 |
| Bürki, C | 1 |
| Engel, MH | 1 |
| Schmidlin, D | 1 |
| Tornic, M | 1 |
| Seifert, B | 1 |
| Jiang, ZY | 1 |
| Costachescu, T | 1 |
| Derouin, M | 1 |
| Gong, F | 2 |
| Shiraishi, H | 2 |
| Kikuchi, Y | 1 |
| Hoshina, M | 1 |
| Ichihashi, K | 1 |
| Sato, Y | 1 |
| Momoi, MY | 2 |
| Tamura, M | 1 |
| Kurumatani, H | 1 |
| Matsushita, T | 1 |
| Gunaydin, S | 1 |
| Imai, Y | 1 |
| Takanashi, Y | 1 |
| Seo, K | 1 |
| Hagino, I | 1 |
| Chang, D | 1 |
| Shinoka, T | 1 |
| Borkenstein, J | 1 |
| Antonov, OS | 1 |
| Vlasov, IuA | 1 |
| Litasova, EE | 1 |
| Obukhov, VN | 1 |
| Pinegin, SL | 1 |
| Simon, H | 1 |
| Felix, R | 1 |
| Hirasima, T | 1 |
| Matsumoto, T | 1 |
| Hirata, N | 1 |
| Kimura, T | 1 |
| Fukuda, K | 1 |
| Takenaka, S | 1 |
| Shima, K | 1 |
| Priebe, HJ | 2 |
| McLean, RF | 1 |
| Prielipp, RC | 2 |
| Tabuchi, H | 1 |
| Kawai, N | 1 |
| Nagasaka, Y | 1 |
| Radermacher, P | 1 |
| Santak, B | 1 |
| Falke, KJ | 1 |
| Zimon, IN | 1 |
| Sen'kin, VV | 1 |
| Miasnik, BN | 1 |
| Palevsky, HI | 1 |
| Fishman, AP | 1 |
| Rasch, DK | 1 |
| Lancaster, L | 1 |
| Frankel, LR | 1 |
| Smith, DW | 1 |
| Lewiston, NJ | 1 |
| Mathru, M | 1 |
| Venus, B | 1 |
| Smith, RA | 1 |
| Shirakawa, Y | 1 |
| Sugiura, A | 1 |
| Gassner, A | 1 |
| Fridrich, L | 1 |
| Magometschnigg, D | 1 |
| Sommer, G | 1 |
| Klicpera, M | 1 |
| Daum, S | 2 |
| Heinl, KW | 2 |
| Hamet, A | 1 |
| Král, B | 1 |
| Cernohorský, D | 1 |
| Gregor, J | 1 |
| Pospísil, M | 1 |
| Tilser, P | 1 |
| Eliás, J | 1 |
| Rozánek, P | 1 |
| Koudelka, V | 1 |
| Sil'vestrov, VP | 1 |
| Surovov, IuA | 1 |
| Semin, SN | 1 |
| Pakulin, IA | 1 |
| Larin, NV | 1 |
| Daskalov, TR | 1 |
| Rudinsky, BF | 1 |
| Komar, KJ | 1 |
| Strates, E | 1 |
| Meadow, WL | 1 |
| Qvist, J | 1 |
| Mygind, T | 1 |
| Crottogini, A | 1 |
| Jordening, H | 1 |
| Mogensen, T | 1 |
| Dorph, S | 1 |
| Laver, MB | 1 |
| Kokosov, AN | 1 |
| Neklasov, IuF | 1 |
| Matkovskiĭ, SK | 2 |
| Kachan, LV | 1 |
| Aleksandrov, AL | 2 |
| Mindich, BP | 1 |
| Ambrose, JA | 1 |
| Teichholz, LE | 1 |
| Damen, J | 1 |
| Hitchcock, JF | 1 |
| Hoit, B | 1 |
| Gregoratos, G | 1 |
| Shabetai, R | 1 |
| Cherniakova, TG | 1 |
| Ilbawi, MN | 1 |
| Idriss, FS | 1 |
| DeLeon, SY | 1 |
| Berry, TE | 1 |
| Duffy, CE | 1 |
| Paul, MH | 1 |
| Ziskind, Z | 1 |
| Pohoryles, L | 1 |
| Mohr, R | 1 |
| Smolinsky, A | 1 |
| Quang, HT | 1 |
| Ruvolo, G | 1 |
| Goor, DA | 1 |
| Ohar, JM | 1 |
| Fowler, AA | 1 |
| Selhorst, JB | 1 |
| Glauser, FL | 1 |
| Shteĭngardt, IuN | 1 |
| Kushner, GA | 1 |
| Zaslavskaia, RM | 1 |
| Degenring, FH | 1 |
| Chepkiĭ, LP | 1 |
| Shubin, MK | 1 |
| Panichkin, IuV | 1 |
| Brusan, LA | 1 |
| Behrenbeck, DW | 2 |
| Schaede, A | 2 |
| Burakovskiĭ, VI | 2 |
| Bukharin, VA | 2 |
| Both, A | 1 |
| Grenzmann, M | 1 |
| Hellwig, H | 1 |
| Wagner, J | 1 |
| Hilger, HH | 1 |
| Plotnikova, LR | 1 |
| Faĭnberg, MA | 1 |
| Begenat, H | 1 |
| Mürtz, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Right Ventricular Function After Withdrawal of Phosphodiesterase-5 Inhibitors in Left Ventricular Assist Device Recipients[NCT04117659] | 32 participants (Actual) | Interventional | 2019-10-15 | Completed | |||
| Assessment of a Peripheral Endothelial Dysfunction in COPD (Chronic Obstructive Pulmonary Disease)[NCT02593357] | 137 participants (Actual) | Interventional | 2012-12-17 | Completed | |||
| Peripheral Endothelial Function in Asthmatic Patients[NCT02593344] | 113 participants (Actual) | Interventional | 2012-12-13 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for nitroglycerin and Pulmonary Hypertension
| Article | Year |
|---|---|
Nitroglycerin inhalation for acute treatment of pulmonary arterial hypertension in children with congenital heart disease.
Topics: Administration, Inhalation; Child; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Nitro | 2021 |
Inhaled alternatives to nitric oxide.
Topics: Administration, Inhalation; Alprostadil; Animals; Epoprostenol; Humans; Hypertension, Pulmonary; Ilo | 2002 |
[CHRONIC COR PULMONALE AS A RESULT OF THROMBOEMBOLIC DISEASES].
Topics: Aminophylline; Coumarins; Drug Therapy; Humans; Hypertension; Hypertension, Pulmonary; Lung; Nitrogl | 1964 |
[A new way for the treatment of pulmonary hypertension: effectiveness of inhalation of nebulized NO donor].
Topics: Administration, Inhalation; Endothelium-Dependent Relaxing Factors; Humans; Hypertension, Pulmonary; | 2004 |
Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
Topics: Adult; Aged; Cardiac Surgical Procedures; Drug Evaluation; Drug Resistance; Female; Hemodynamics; Hu | 2005 |
Neonatal 'pulmonary vasodilator' drugs. Current status.
Topics: Acetylcholine; Animals; Calcium Channel Blockers; Cardiac Output; Catecholamines; Humans; Hypertensi | 1984 |
Persistent pulmonary hypertension of the neonate (persistent fetal circulation syndrome).
Topics: Acetylcholine; Calcium; Catecholamines; Epoprostenol; Homeostasis; Humans; Hypertension, Pulmonary; | 1983 |
Nitroglycerin therapy in the management of pulmonary hypertensive disorders.
Topics: Humans; Hypertension, Pulmonary; Nitroglycerin; Pulmonary Wedge Pressure; Vascular Resistance; Vasod | 1984 |
Vasodilator therapy for primary pulmonary hypertension.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Calcium Channel Blockers; Hum | 1985 |
9 trials available for nitroglycerin and Pulmonary Hypertension
| Article | Year |
|---|---|
Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study.
Topics: Adolescent; Adrenergic beta-1 Receptor Agonists; Adult; Dobutamine; Dose-Response Relationship, Drug | 2018 |
Inhaled nitroglycerin versus inhaled milrinone in children with congenital heart disease suffering from pulmonary artery hypertension.
Topics: Administration, Inhalation; Child; Child, Preschool; Female; Heart Defects, Congenital; Humans; Hype | 2010 |
Efficiency of prostacyclin in the treatment of protamine-mediated right ventricular failure and acute pulmonary hypertension.
Topics: Acute Disease; Adrenergic alpha-Agonists; Adult; Aged; Antihypertensive Agents; Capillaries; Cardiot | 2005 |
A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery.
Topics: Drug Therapy, Combination; Female; Follow-Up Studies; Heart Valve Diseases; Heart Valve Prosthesis I | 2006 |
Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
Topics: Administration, Inhalation; Adult; Brachial Artery; Endothelium, Vascular; Female; Humans; Hypertens | 2007 |
Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
Topics: Administration, Inhalation; Adult; Brachial Artery; Endothelium, Vascular; Female; Humans; Hypertens | 2007 |
Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
Topics: Administration, Inhalation; Adult; Brachial Artery; Endothelium, Vascular; Female; Humans; Hypertens | 2007 |
Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
Topics: Administration, Inhalation; Adult; Brachial Artery; Endothelium, Vascular; Female; Humans; Hypertens | 2007 |
Markers of pulmonary hypertension in potential candidates to heart transplantation.
Topics: Adult; Biomarkers; Cardiomyopathy, Dilated; Dose-Response Relationship, Drug; Drug Resistance; Femal | 2006 |
Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.
Topics: Administration, Inhalation; Aged; Cardiac Output, Low; Cardiopulmonary Bypass; Catheterization, Swan | 2008 |
Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension.
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Cardiac Output; Cardiopulmonary Bypass; Cardi | 1997 |
Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
Topics: Administration, Inhalation; Adult; Aged; Alprostadil; Blood Pressure; Cardiac Output; Cardiac Surgic | 1999 |
90 other studies available for nitroglycerin and Pulmonary Hypertension
| Article | Year |
|---|---|
Pulmonary Vasodilation by Intravenous Infusion of Organic Mononitrites Of 1,2-Propanediol in Acute Pulmonary Hypertension Induced by Aortic Cross Clamping and Reperfusion: A Comparison With Nitroglycerin in Anesthetized Pigs.
Topics: Animals; Disease Models, Animal; Female; Hypertension, Pulmonary; Infusions, Intravenous; Male; Nitr | 2020 |
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
Topics: Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hy | 2018 |
Organic mononitrites of 1,2-propanediol act as an effective NO-releasing vasodilator in pulmonary hypertension and exhibit no cross-tolerance with nitroglycerin in anesthetized pigs.
Topics: Animals; Dose-Response Relationship, Drug; Drug Tolerance; Hypertension, Pulmonary; Infusions, Intra | 2018 |
Effectiveness of Nitroglycerin in Managing Subacute Lung Bleeding Induced by Balloon Pulmonary Angioplasty.
Topics: Administration, Intravenous; Aged; Angiography; Angioplasty, Balloon; Female; Hemoptysis; Humans; Hy | 2018 |
Intravenous anesthesia with nitroglycerin inhalation for surgical abortion in a patient with severe congenital heart disease and low oxygen saturation: A case report.
Topics: Abortion, Induced; Adult; Anesthesia, Intravenous; Blood Gas Analysis; Blood Pressure Determination; | 2018 |
The effects of cardiac output and pulmonary arterial hypertension on volumetric capnography derived-variables during normoxia and hypoxia.
Topics: Anesthesia; Animals; Capnography; Carbon Monoxide; Cardiac Output; Dobutamine; Hemodynamics; Hyperte | 2015 |
Effects of streptozotocin-induced diabetes on the pharmacology of rat conduit and resistance intrapulmonary arteries.
Topics: Animals; Calcium Signaling; Carbachol; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dinop | 2009 |
Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.
Topics: Cyclic GMP; Drug Therapy, Combination; Heart Failure; Humans; Hypertension, Pulmonary; Isosorbide Di | 2009 |
ALERT: Revatio is another brand name for sildenafil.
Topics: Canada; Contraindications; Drug Interactions; Female; Humans; Hypertension, Pulmonary; Medication Er | 2009 |
Efficacy of milrinone versus nitroglycerin in controlling pulmonary arterial hypertension induced by intravenous injections of absolute ethanol in anesthetized dogs.
Topics: Animals; Antihypertensive Agents; Dogs; Ethanol; Female; Hypertension, Pulmonary; Injections, Intrav | 2010 |
Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
Topics: Aged; Analysis of Variance; Cardiac Catheterization; Cardiotonic Agents; Female; Heart Failure; Hear | 2003 |
Effect of nitroglycerin inhalation on patients with pulmonary hypertension undergoing mitral valve replacement surgery.
Topics: Administration, Inhalation; Adult; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Midd | 2003 |
[The effects of hypertonic NaCl (7.5%) in dogs with induced acute pulmonary artery obstruction].
Topics: Animals; Dogs; Female; Hemodynamics; Hypertension, Pulmonary; Infusions, Intravenous; Male; Nitrogly | 2003 |
Combination of phenoxybenzamine and nitroglycerin: effective control of pulmonary artery pressures in children undergoing cardiac surgery.
Topics: Blood Pressure; Cardiac Surgical Procedures; Child; Drug Combinations; Humans; Hypertension, Pulmona | 2005 |
Evidence for systemic endothelial dysfunction in patients and first-order relatives with pulmonary arterial hypertension.
Topics: Brachial Artery; Endothelial Cells; Humans; Hypertension, Pulmonary; Nitroglycerin | 2005 |
Evidence for systemic endothelial dysfunction in patients and first-order relatives with pulmonary arterial hypertension.
Topics: Brachial Artery; Endothelial Cells; Humans; Hypertension, Pulmonary; Nitroglycerin | 2005 |
Evidence for systemic endothelial dysfunction in patients and first-order relatives with pulmonary arterial hypertension.
Topics: Brachial Artery; Endothelial Cells; Humans; Hypertension, Pulmonary; Nitroglycerin | 2005 |
Evidence for systemic endothelial dysfunction in patients and first-order relatives with pulmonary arterial hypertension.
Topics: Brachial Artery; Endothelial Cells; Humans; Hypertension, Pulmonary; Nitroglycerin | 2005 |
Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
Topics: Adult; Aged; Antihypertensive Agents; Cardiac Output; Female; Heart Failure; Heart Valve Diseases; H | 2006 |
Efficacy of nitroglycerin inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease.
Topics: Administration, Inhalation; Blood Flow Velocity; Blood Pressure; Cardiac Catheterization; Child, Pre | 2006 |
Inhalation of nebulized nitroglycerin, a nitric oxide donor, for the treatment of pulmonary hypertension induced by high pulmonary blood flow.
Topics: Administration, Inhalation; Animals; Blood Pressure; Cell Proliferation; Endothelial Cells; Hyperten | 2006 |
Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
Topics: Administration, Inhalation; Adult; Aged; Cardiac Catheterization; Female; Heart Failure; Heart Trans | 2007 |
A profile of intravenous nitroglycerin use in cardiopulmonary bypass surgery.
Topics: Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiovascular Diseases; Coronary Disease; Fema | 1983 |
Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study.
Topics: Adult; Aged; Female; Heart; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Lung Disease | 1983 |
Pulmonary vasodilator effects of nitroglycerin and sodium nitroprusside in canine oleic acid-induced pulmonary hypertension.
Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Ferricyanides; Hypertension, Pulmonary; Lung; Nitrogl | 1983 |
Acute hemodynamic effects of nitroglycerin in pulmonary hypertension.
Topics: Adult; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Midd | 1983 |
Haemodynamic effects of nifedipine, nitroglycerine and prazosin in pulmonary hypertension following ingestion of toxic oil.
Topics: Adolescent; Adult; Child; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; | 1983 |
[Role of biogenic amines in the etiology of pulmonary hypertension in chronic nonspecific lung diseases and the effect of sustac].
Topics: Adult; Aged; Antihypertensive Agents; Bronchitis; Catecholamines; Chronic Disease; Humans; Hypertens | 1983 |
Vasodilator effect on right ventricular function in congestive heart failure and pulmonary hypertension: end-systolic pressure--volume relation.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Ferricyanides; Heart Failure; Heart Ventricles; | 1984 |
Partial reversibility of chronic pulmonary hypertension caused by pulmonary thromboembolic disease.
Topics: Adult; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Isoproterenol; Male; Middle Aged; Nitr | 1981 |
Intravenous nitroglycerin in acute respiratory failure of patients with chronic obstructive lung disease, secondary pulmonary hypertension and cor pulmonale.
Topics: Acute Disease; Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Injections, Intra | 1982 |
[Evaluation of intravenous nitroglycerin in the management of pulmonary hypertension in complete transposition of great vessels late after operation (author's transl)].
Topics: Child, Preschool; Female; Humans; Hypertension, Pulmonary; Injections, Intravenous; Male; Nitroglyce | 1982 |
Endothelin receptor antagonists in a beagle model of pulmonary hypertension: contribution to possible potential therapy?
Topics: Alprostadil; Animals; Azepines; Dogs; Endothelin Receptor Antagonists; Hemodynamics; Hypertension, P | 1995 |
[Individual approach to vasodilator treatment of pulmonary hypertension in chronic bronchitis].
Topics: Adult; Aminophylline; Bronchitis; Chronic Disease; Humans; Hydralazine; Hypertension, Pulmonary; Mid | 1994 |
Effect of inhaled nitric oxide on pulmonary hemodynamics after acute lung injury in dogs.
Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Animals; Blood Pressure; Carboxyhemoglobin; | 1994 |
[Effects of ligustrazine and nitroglycerine on acute hypoxic pulmonary hypertension in anesthetized dogs].
Topics: Acute Disease; Animals; Blood Pressure; Calcium Channel Blockers; Dogs; Female; Hypertension, Pulmon | 1994 |
Effects of continuous infusion of nitroglycerin on pulmonary hemodynamics, lung lymph balance, and prostanoid products in the response to endotoxin in awake sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Consciousness; Endotoxins; Hypertension, Pulmonary; Infusions | 1993 |
Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Arginine; Calcimycin; Dose-Response Relationship, Dru | 1995 |
Moderate primary pulmonary hypertension in patients undergoing liver transplantation.
Topics: Adult; Blood Pressure; Cardiac Output; Cardiopulmonary Bypass; Case-Control Studies; Central Venous | 1996 |
Inhibition of endogenous nitric oxide synthase potentiates nitrovasodilators in experimental pulmonary hypertension.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Alprostadil; Animals; Drug Synergism; Enzyme Inhibitor | 1996 |
Combination of inhaled nitric oxide with i.v. nitroglycerin or with a prostacyclin analogue in the treatment of experimental pulmonary hypertension.
Topics: Administration, Inhalation; Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fe | 1996 |
Comparison of the effect of inhaled nitric oxide and intravenous nitroglycerine on hypoxia-induced pulmonary hypertension in pigs.
Topics: Administration, Inhalation; Animals; Female; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Infusio | 1996 |
Effect of nitroglycerin in patients with increased pulmonary vascular resistance undergoing cardiac transplantation.
Topics: Acute Disease; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Hypertension | 1997 |
Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction.
Topics: Administration, Inhalation; Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Disease M | 1998 |
Novel catheterization technique for the in vivo measurement of pulmonary vascular responses in rats.
Topics: Acetylcholine; Animals; Blood Pressure; Bradykinin; Calcitonin Gene-Related Peptide; Cardiac Cathete | 1998 |
Cesarean section in a mother with uncorrected congenital coronary to pulmonary artery fistula.
Topics: Adult; Analgesics, Opioid; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthesia, Obstetrical; | 1999 |
Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Female; Heart | 1999 |
Treatment of pulmonary hypertension during surgery with nitric oxide and vasodilators.
Topics: Administration, Inhalation; Colectomy; Cyclic GMP; Dipyridamole; Female; Hemodynamics; Humans; Hyper | 2000 |
Inhalation of nebulized nitroglycerin in dogs with experimental pulmonary hypertension induced by U46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Anim | 2000 |
Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Antihypert | 2001 |
The effects of inhalation of nebulized nitroglycerin on dogs with experimental pulmonary hypertension induced by U46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Anim | 2000 |
The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Calcium Channel Blockers; Cardiopulm | 2002 |
[The distribution of ventilation and perfusion in the obstructive syndrome during nitroglycerin and bronchospasmolytic therapy].
Topics: Aged; Fenoterol; Humans; Hypertension, Pulmonary; Hypoxia; Lung; Lung Diseases, Obstructive; Male; M | 1979 |
[Study of the pulmonary vessel reaction to administration of carbon dioxide and nitroglycerin in congenital heart defects complicated by high pulmonary hypertension].
Topics: Adolescent; Adult; Blood Pressure; Carbon Dioxide; Child; Child, Preschool; Heart Defects, Congenita | 1977 |
[Reversible pulmonary arterial hypertension after medication of aminorexfumarate (author's transl)].
Topics: Aminorex; Blood Pressure; Cardiac Catheterization; Female; Humans; Hypertension, Pulmonary; Middle A | 1977 |
[The effects of oxygen and vasodilators on pulmonary hemodynamics and blood gases in chronic lung disease].
Topics: Aged; Alprostadil; Chronic Disease; Female; Humans; Hypertension, Pulmonary; Lung Diseases; Male; Mi | 1992 |
Myocardial ischemia during vasodilator therapy in a canine model of pulmonary hypertension and coronary insufficiency.
Topics: Alprostadil; Animals; Coronary Disease; Coronary Vessels; Dogs; Hemodynamics; Hydralazine; Hypertens | 1992 |
Vasodilator therapy in microembolic porcine pulmonary hypertension.
Topics: Alprostadil; Animals; Ferricyanides; Hemodynamics; Hydralazine; Hypertension, Pulmonary; Infusions, | 1990 |
[Favorable effect of long-term oxygen and vasodilator therapy in a patient with pulmonary hypertension associated with liver cirrhosis].
Topics: Humans; Hypertension, Pulmonary; Liver Cirrhosis; Male; Middle Aged; Nitroglycerin; Oxygen Inhalatio | 1990 |
Comparison of prostaglandin E1 and nitroglycerin in patients with ARDS.
Topics: Alprostadil; Blood Pressure; Humans; Hypertension, Pulmonary; Nitroglycerin; Pulmonary Circulation; | 1989 |
[Correction of pulmonary hypertension in heart surgery patients during the immediate postoperative period].
Topics: Aminophylline; Delayed-Action Preparations; Hemodynamics; Humans; Hypertension, Pulmonary; Mitral Va | 1989 |
Successful use of nitroglycerin to treat postoperative pulmonary hypertension.
Topics: Child, Preschool; Down Syndrome; Female; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; | 1987 |
Cardiac output effects of nitroglycerin in experimental lung injury.
Topics: Animals; Cardiac Output; Dogs; Humans; Hypertension, Pulmonary; Lung; Nitroglycerin; Oleic Acid; Ole | 1986 |
Nitroglycerin-responsive pulmonary hypertension in idiopathic pulmonary hemosiderosis.
Topics: Child; Hemosiderosis; Humans; Hypertension, Pulmonary; Lung Diseases; Male; Nitroglycerin | 1986 |
Treatment of low cardiac output complicating acute pulmonary hypertension in normovolemic goats.
Topics: Animals; Cardiac Output, Low; Dopamine; Goats; Hemodynamics; Hypertension, Pulmonary; Isoproterenol; | 1986 |
[Vasodilator therapy in pulmonary hypertension and chronic obstructive lung disease (COPD). Hemodynamic studies exemplified by nifedipine and nitroglycerin].
Topics: Exercise Test; Hemodynamics; Humans; Hypertension, Pulmonary; Long-Term Care; Lung Diseases, Obstruc | 1986 |
Treatment of pulmonary hypertension with transdermal nitroglycerin.
Topics: Administration, Cutaneous; Blood Pressure; Female; Humans; Hypertension, Pulmonary; Male; Middle Age | 1986 |
[Transdermal nitroglycerin in the treatment of pulmonary hypertension].
Topics: Administration, Cutaneous; Blood Pressure; Delayed-Action Preparations; Female; Humans; Hypertension | 1986 |
[Nitrates in the treatment of hypoxic pulmonary hypertension].
Topics: Adult; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nitroglycerin; Oxyg | 1987 |
[Corrective effect of nitrates and calcium antagonists on hemodynamics and ventilation in chronic bronchitis patients with a syndrome of pulmonary hypertension].
Topics: Bronchitis; Calcium Channel Blockers; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension, | 1987 |
Application of a combination of sublingually administered vasodilating drugs for rapid action on pulmonary hypertension in patients with cardiac asthma and with pulmonary oedema.
Topics: Administration, Oral; Adult; Aged; Drug Therapy, Combination; Dyspnea, Paroxysmal; Female; Heart Fai | 1987 |
Neither nitroglycerin nor nitroprusside selectively reduces sepsis-induced pulmonary hypertension in piglets.
Topics: Animals; Aorta; Blood Pressure; Disease Models, Animal; Drug Evaluation, Preclinical; Ferricyanides; | 1987 |
Cardiovascular adjustments to pulmonary vascular injury in dogs.
Topics: Animals; Blood Volume; Dogs; Dopamine; Hemodynamics; Hypertension, Pulmonary; Intra-Aortic Balloon P | 1988 |
Vasodilator therapy in vasoconstrictor-induced pulmonary hypertension in sheep.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Disease Mo | 1988 |
Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension.
Topics: Alprostadil; Animals; Coronary Circulation; Disease Models, Animal; Dogs; Female; Heart Ventricles; | 1988 |
[Characteristics of the course of pulmonary hypertension in patients with chronic obstructive bronchitis (2)].
Topics: Adolescent; Adult; Aged; Bronchitis; Chronic Disease; Hemodynamics; Humans; Hypertension; Hypertensi | 1988 |
Effect of nitroglycerin on the pulmonary venous gradient in patients after mitral valve replacement.
Topics: Adult; Aged; Blood Flow Velocity; Blood Pressure; Female; Heart Atria; Heart Valve Prosthesis; Human | 1985 |
Reactive pulmonary hypertension after a switch operation. Successful treatment with glyceryl trinitrate.
Topics: Cardiopulmonary Bypass; Humans; Hypertension, Pulmonary; Infant; Male; Nitroglycerin; Transposition | 1985 |
Paradoxical pulmonary vasoconstriction induced by nitroglycerin in idiopathic pulmonary hypertension.
Topics: Adolescent; Cardiac Catheterization; Constriction, Pathologic; Female; Humans; Hypertension, Pulmona | 1985 |
[Effect of nitroglycerin on various indicators of hemodynamics in patients with chronic obstructive bronchitis complicated by pulmonary hypertension].
Topics: Adult; Blood Pressure; Blood Volume; Bronchitis; Cardiac Output; Chronic Disease; Hemodynamics; Huma | 1985 |
Hemodynamic effects of intravenous nitroglycerin in pediatric patients after heart surgery.
Topics: Cardiac Output; Child; Child, Preschool; Dose-Response Relationship, Drug; Heart Defects, Congenital | 1985 |
The effect of low-dose intravenous nitroglycerin on pulmonary hypertension immediately after replacement of a stenotic mitral valve.
Topics: Adolescent; Adult; Aged; Cardiac Output; Female; Heart Valve Prosthesis; Humans; Hypertension, Pulmo | 1985 |
Intravenous nitroglycerin-induced intracranial hypertension.
Topics: Female; Humans; Hypertension, Pulmonary; Infusions, Parenteral; Intracranial Pressure; Middle Aged; | 1985 |
[Effect of nitroglycerin on pulmonary hemodynamics in patients with chronic bronchitis and pulmonary emphysema without pulmonary hypertension and cor pulmonale].
Topics: Adult; Bronchitis; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Nitroglycerin; Pulmon | 1985 |
[Antiserotonin action of several pharmacological substances on the vessels of the lungs and bronchi].
Topics: Aminophylline; Analgesics; Animals; Atropine; Blood Pressure; Bronchial Spasm; Epinephrine; Fibrinol | 1969 |
[The therapeutic modification of the primary vascular form of chronic cor pulmonale and of continuing pulmonary hypertension after commissurotomy for mitral stenosis. A comparison with control of the pulmonary artery pressure].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Cardi | 1970 |
[Effect of nitroglycerin on hemodynamics in patients with congenital heart defects associated with and without pulmonary hypertension].
Topics: Child; Heart Defects, Congenital; Hemodynamics; Humans; Hypertension, Pulmonary; Nitroglycerin | 1972 |
[Pharmacological studies on the therapy of pulmonary hypertension in humans].
Topics: Female; Humans; Hypertension, Pulmonary; Male; Metaproterenol; Nitroglycerin; Resorcinols | 1969 |
[Basic surgical problems in congenital heart defects].
Topics: Age Factors; Aortic Coarctation; Aortic Valve Stenosis; Child; Child, Preschool; Heart Defects, Cong | 1969 |
[Therapy of primary pulmonary hypertension].
Topics: Acetylcholine; Amino Alcohols; Carbachol; Child; Diazepam; Diazoxide; Female; Humans; Hypertension, | 1970 |
[Studies on the therapy of pulmonary hypertension of cardiac, pulmonary and vascular genesis using repeated pulmonary artery pressure monitoring].
Topics: Adult; Blood Pressure Determination; Female; Humans; Hypertension, Pulmonary; Nitroglycerin; Pulmona | 1969 |
[Pharmacologic tests for evaluation of the state of the pulmonary vessels in patients with congenital heart defects and severe pulmonary hypertension].
Topics: Acetylcholine; Adolescent; Aminophylline; Blood Flow Velocity; Cardiac Catheterization; Child; Femal | 1971 |
[Pulmonary circulation in primary pulmonary hypertension during hyperoxia and following drugs].
Topics: Adult; Blood Gas Analysis; Blood Pressure Determination; Cardiac Output; Humans; Hypertension, Pulmo | 1971 |